Journal profile · Pathology
Cytopathology
ISSN 0956-5507 · eISSN 1365-2303 · Wiley-Blackwell Publishing Ltd · ENGLAND · Bimonthly · Founded 1990
Cytopathology: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 1.2; hybrid open access; APC about USD 3,900; median 105 days to acceptance (94 articles, last 24 months); community-reported acceptance: fairly easy; 105 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Cytopathology is published by Wiley-Blackwell Publishing Ltd and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Cervical Cancer and HPV Research, Salivary Gland Tumors Diagnosis and Treatment and Breast Lesions and Carcinomas, together about 30.5% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
The aim of Cytopathology is to publish articles relating to those aspects of cytology which will increase our knowledge and understanding of the aetiology, diagnosis and management of human disease. It contains original articles and critical reviews on all aspects of clinical cytology in its broadest sense, including: gynaecological and non-gynaecological cytology fine needle aspiration and screening strategy. Cytopathology welcomes papers and articles on: ultrastructural, histochemical and immunocytochemical studies of the cell quantitative cytology and DNA hybridization as applied to cytological material Editorial policy reflects the interest of cytopathologists and cytotechnologists alike as well as the interests of clinicians using the cytology service. It also reflects the interest of biological scientists whose work involves research at the cellular level. Negative/null results In order for research to advance, negative results, which often make a valuable contribution to the field, should be published. However, articles containing negative or null results are frequently not considered for publication or rejected by journals. We welcome papers of this kind, where appropriate and valid power calculations are included that give confidence that a negative result can be relied upon.
From the journal's Aims & Scope
Research area (LetPub): Pathology
Editor-in-chief Philippe Vielh MedipathPublisher website
Editorial board by country: 4 in mainland China (about 3%); most named United States 48, United Kingdom 15, Italy 10, Spain 6, Japan 5 (137 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Cervical Cancer and HPV ResearchMedicine17%
- Salivary Gland Tumors Diagnosis and TreatmentMedicine7.4%
- Breast Lesions and CarcinomasMedicine6.2%
- Thyroid Cancer Diagnosis and TreatmentMedicine5.7%
- Cancer and Skin LesionsMedicine4.5%
- Cancer and biochemical researchBiochemistry, Genetics and Molecular Biology4.1%
- Global Cancer Incidence and ScreeningMedicine4.1%
- Endometrial and Cervical Cancer TreatmentsMedicine4%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Cell Biology | Zone 4 |
| Minor | Pathology | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Cell Biology | Zone 4 |
| Minor | Pathology | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Cell Biology | Zone 4 |
| Minor | Pathology | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
MEDLINEPubMedEmbaseCAB AbstractsCurrent ContentsPublisher website
Other: EBSCO, AGRICOLA
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 1.2LetPub ·
- Impact factor (publisher)
- 1.2Publisher website ·
- Impact factor (publisher) 2025
- 1.2Publisher website ·
- CiteScore 2026-06
- 2.3LetPub ·
- CiteScore (publisher)
- 2.3Publisher website ·
- CiteScore (publisher) 2025
- 2.3Publisher website ·
- SJR 2026-06
- 0.39LetPub ·
- SNIP 2026-06
- 0.64LetPub ·
- h-index
- 42LetPub ·
- h-index
- 67OpenAlex ·
- i10-index
- 1,041OpenAlex ·
- 2-year mean citedness
- 1.12OpenAlex ·
- Self-citation rate
- 8.3%LetPub ·
- Share of gold OA articles
- 19.51%LetPub ·
Volume
- Articles per year
- 81LetPub ·
- Articles per year (publisher) 2025
- 90Publisher website ·
- Downloads per year (publisher) 2025
- 115,954Publisher website ·
Articles by year OpenAlex count · 3,944 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 87 | 53 | 11 |
| 2025 | 105 | 45 | 98 |
| 2024 | 115 | 55 | 236 |
| 2023 | 157 | 84 | 472 |
| 2022 | 118 | 22 | 475 |
| 2021 | 150 | 21 | 743 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
105 daysMedian, submission to acceptance · P25–P75 66 days – 158 days
- Acceptance to online
- median 14 days (95 articles)
- Submission to online
- median 121 days
- Sample
- 94 articles with submission and acceptance dates (201 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- 6–12 weeksLetPub ·
- Average acceptance (community reports)
- Fairly easyLetPub ·
- Acceptance rate (publisher)
- 28%Publisher website ·
- Acceptance rate (publisher) 2025
- 28%Publisher website ·
- Submission to first decision
- 16 daysPublisher website ·
- Submission to first decision 2025
- 16 daysPublisher website ·
- Submission to acceptance 2025
- 95 daysPublisher website ·
- Acceptance to publication 2025
- 12 daysPublisher website ·
- Peer review
- Single anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 3,900 / EUR 3,270 / GBP 2,540 | — | — | |
| Publisher website | Yes, amount not published | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Article types accepted10
- case report• Original Articles – Reports of new research findings or conceptual analyses that make a significant contribution to knowledge. Structured abstract required an…Length not stated
- correspondence• Original Articles – Reports of new research findings or conceptual analyses that make a significant contribution to knowledge. Structured abstract required an…Length not stated
- editorial• Original Articles – Reports of new research findings or conceptual analyses that make a significant contribution to knowledge. Structured abstract required an…Length not stated
- editorial articles/review articlesEditorial Articles/Review Articles - These will be invited by the editor(s).Length not stated
- incytInCyt – Invited by the editor(s).Length not stated
- letter• Original Articles – Reports of new research findings or conceptual analyses that make a significant contribution to knowledge. Structured abstract required an…Length not stated
- original article• Original Articles – Reports of new research findings or conceptual analyses that make a significant contribution to knowledge. Structured abstract required an…Length not stated
- original articlesOriginal Articles – Reports of new research findings or conceptual analyses that make a significant contribution to knowledge. Structured abstract required and …Length not stated
- review• Original Articles – Reports of new research findings or conceptual analyses that make a significant contribution to knowledge. Structured abstract required an…Length not stated
- review article• Original Articles – Reports of new research findings or conceptual analyses that make a significant contribution to knowledge. Structured abstract required an…Length not stated
Policy excerpts from the journal's websitePublication ethics, License & copyright, Peer review, Preprints
- Publication ethics 5. EDITORIAL POLICIES AND ETHICAL CONSIDERATIONS
Submission implies content not published or submitted elsewhere except as a brief abstract in proceedings. Model summary
Editorial Review and AcceptanceThe acceptance criteria for all papers are the quality and originality of the research and its significance to our readership. Except where otherwise stated, manuscripts are single-blind peer reviewed. Papers will only be sent to review if the Editors-in-Chief determine that the paper meets the appropriate quality and relevance requirements. Wiley's policy on confide…
Source ↗Publisher website ·- License & copyright
Licensing: standard copyright agreement or open access under a Creative Commons License. Model summary
Authors may choose to publish under the terms of the journal’s standard copyright agreement, or open access under the terms of a Creative Commons License.
Source ↗Publisher website ·- Peer review
Peer review: single-blind; papers sent to review only if Editors-in-Chief determine quality and relevance requirements are met. Model summary
Except where otherwise stated, manuscripts are single-blind peer reviewed. Papers will only be sent to review if the Editors-in-Chief determine that the paper meets the appropriate quality and relevance requirements.
Source ↗Publisher website ·- Preprints Preprint Policy:
Preprint policy: considers preprints on non-commercial servers; authors may post submitted version to non-commercial servers at any time. Model summary
Wiley believes that journals publishing for communities with established pre-print servers should allow authors to submit manuscripts which have already been made available on a non-commercial preprint server. Allowing submission does not, of course, guarantee that an article will be sent out for review. It simply reflects our belief that journals should not rule out reviewing a paper simply becau…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Wiley-Blackwell Publishing Ltd
- Country or region
- ENGLAND
- Language
- English
- Frequency
- Bimonthly
- Founded
- 1990
- ISSN
- 0956-5507
- Electronic ISSN
- 1365-2303
- Latest issue on the website
- Volume 37, Issue 5 (September 2026)
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗LetPub
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Cytopathology
What CAS zone is Cytopathology in?
In the 2025 upgraded edition of the CAS Journal Ranking, Cytopathology is in Zone 4 of Medicine, and in Zone 4 of the minor category Cell Biology / Pathology. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Cytopathology?
The latest impact factor listed by LetPub is 1.2; CiteScore 2.3, h-index 67.
How long does peer review take at Cytopathology?
Based on the dates recorded on 94 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 105 days (interquartile range 66–158 days); authors report an average review time of 6–12 weeks; the community-reported acceptance is “Fairly easy”; the journal's website gives an acceptance rate of 28% (2025). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of Cytopathology based?
Of the 137 board members whose country the journal's board page names, 4 (about 3%) are in mainland China; the countries named most often are United States (48), United Kingdom (15) and Italy (10). Counted from the institutions listed on the board page; for reference only.
Which databases index Cytopathology?
According to LetPub and DOAJ records, Cytopathology is indexed in SCIE and Scopus. The journal's website also lists MEDLINE, PubMed, Embase, CAB Abstracts and Current Contents; that list has not been checked against each database.
Is Cytopathology open access, and what is the APC?
Cytopathology is a hybrid journal. For open-access publication: APC about USD 3,900.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .